Publications by authors named "Siddhartha Garg"
Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience.
Epilepsy Behav
May 2022
Article Synopsis
- The study aimed to evaluate the effectiveness and safety of clobazam as an add-on therapy for patients with epilepsy whose seizures were not well-controlled by single antiseizure medications (ASM).
- Conducted in India, the research followed 429 patients over one year, assessing seizure control and adverse effects through interviews and diaries.
- Results showed that 83.4% of the patients remained seizure-free after one year, and clobazam was well-tolerated, although 22.6% experienced adverse events.
Objective: The objective of the present study was to assess the impact of neurological consultation and intervention upon patient outcome in intensive care unit (ICU).
Settings: A retrospective observational study was conducted in the 24-bedded multispecialty ICU of a 350 bedded tertiary care hospital over 8 months period, from January 2011 to August 2011. Critically, ill-patients with varied neurological symptomatology affecting the course of illness and ICU discharge were included.
Objective: To report and discuss twelve cases of Valproate (VPA) induced hyperammonaemic encephalopathy without liver failure in subjects receiving VPA therapy.
Methods: This study was conducted in the department of Neurology, G.B.
Cerebral venous thrombosis (CVT) is an under diagnosed condition for acute or slowly progressive neurological deficit. CVT is less frequent than arterial thrombosis. CVT has a wide spectrum of signs and symptoms, which may evolve suddenly or over the weeks.
View Article and Find Full Text PDF